With the unrestricted educational grant of:
PATHOPHYSIOLOGY OF AA AND PNH
Chairs: G. Di Minno, A.M. Risitano
Special Lecture: Pathophysiology of Aplastic Anemia and PNH: what we know and what we don’t yet know
L. Luzzatto
The immune system and telomeres in AA
R.T. Calado
SOMATIC MUTATIONS IN BONE MARROW FAILURE SYNDROMES
Chairs: M. Cazzola, G. Pizzolo
Somatic mutations in AA
A.G. Kulasekararaj
Debate: is PNH a myeloid malignancy? No
A.M. Risitano
NON-TRANSPLANT TREATMENT OF AA
Chairs: S. Nakao, P. Scheinberg
Special Lecture: The treatment of AA
N.S. Young
Debate: is hATG the only ATG preparation? Yes
C. Dufour
Debate: is hATG the only ATG preparation? No
A. Bacigalupo
ELTROMBOPAG: EMERGING DATA IN BMF
Chairs: C. Selleri, N.S. Young
Eltrombopag in AA: the US experience
P. Scheinberg
Eltrombopag and IST: the EU experience
R. Peffault de Latour
Eltrombopag and MDS: is there any room?
R. Latagliata
Keynote Lecture: The new era of complement inhibition for PNH
A.M. Risitano
NON-TRANSPLANT TREATMENT OF PNH - Proximal complement inhibitors
Chairs: T. Kinoshita, L. Luzzatto
Anti-Factor D: ACH-4471
A.G. Kulasekararaj
Anti-Factor B: LNP023
A.M. Risitano
HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AA AND PNH
Chairs: J.R. Passweg, R. Peffault de Latour
HSCT for pediatric AA
C. Dufour
HSCT for adults AA
A. Bacigalupo
HSCT for PNH
R. Peffault de Latour
NOVEL STRATEGIES OF TRANSPLANTATION
Chairs: A. Bacigalupo, C. Dufour
The FCC platform and haplo PT-Cy
A. Pagliuca
Cord blood transplantation
A. Ruggeri
ROUND TABLE: THE FUTURE TRIALS FOR AA
Chairs: R.T. Calado, R. Peffaut de Latour, A.M. Risitano, P. Scheinberg, N.S. Young
Proposals from the SAAWP of the EBMT
R. Peffault de Latour, A.M. Risitano
Proposals from the South America AA group
R.T. Calado, P. Scheinberg
Proposals from the NIH
N.S. Young
